Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists demonstrated that salinomycin displayed potent anti-fibrotic activity in cardiac fibroblasts obtained from heart failure patients. In pre-clinical studies, salinomycin prevented cardiac fibrosis and functional decline in mouse models of ischemic and non-ischemic heart disease.
[Circulation Research]
1254621 {1254621:JKX33RS4} apa 50 1 161027 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-5430dc2db866f053e3a8295b8c778cb1%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22JKX33RS4%22%2C%22library%22%3A%7B%22id%22%3A1254621%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Burke%20Ryan%20M%20et%20al.%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBurke%20Ryan%20M%2C%20Dirkx%2C%20Jr.%20R.%20A.%2C%20Quijada%20Pearl%2C%20Lighthouse%20Janet%20K%2C%20Mohan%20Amy%2C%20O%26%23x2019%3BBrien%20Meghann%2C%20Wojciechowski%20Wojciech%2C%20Woeller%20Collynn%2C%20Phipps%20Richard%20P%2C%20Alexis%20Jeffrey%20D%2C%20Ashton%20John%2C%20%26amp%3B%20Small%20Eric%20M.%20%28n.d.%29.%20Prevention%20of%20Fibrosis%20and%20Pathological%20Cardiac%20Remodeling%20by%20Salinomycin.%20%3Ci%3ECirculation%20Research%3C%5C%2Fi%3E%2C%20%3Ci%3E0%3C%5C%2Fi%3E%280%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCRESAHA.120.317791%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1161%5C%2FCIRCRESAHA.120.317791%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D1254621%26amp%3Bitem_key%3DJKX33RS4%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prevention%20of%20Fibrosis%20and%20Pathological%20Cardiac%20Remodeling%20by%20Salinomycin%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Burke%20Ryan%20M%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jr.%20Ronald%20A%22%2C%22lastName%22%3A%22Dirkx%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Quijada%20Pearl%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Lighthouse%20Janet%20K%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Mohan%20Amy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22O%27Brien%20Meghann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Wojciechowski%20Wojciech%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Woeller%20Collynn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Phipps%20Richard%20P%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Alexis%20Jeffrey%20D%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Ashton%20John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Small%20Eric%20M%22%7D%5D%2C%22abstractNote%22%3A%22Rationale%3A%20Cardiomyopathy%20is%20characterized%20by%20the%20deposition%20of%20extracellular%20matrix%20by%20activated%20resident%20cardiac%20fibroblasts%2C%20called%20myofibroblasts.%20There%20are%20currently%20no%20therapeutic%20approaches%20to%20blunt%20the%20development%20of%20pathological%20fibrosis%20and%20ventricle%20chamber%20stiffening%20that%20ultimately%20leads%20to%20heart%20failure.%20Objective%3A%20We%20undertook%20a%20high-throughput%20screen%20to%20identify%20small%20molecule%20inhibitors%20of%20myofibroblast%20activation%20that%20might%20limit%20the%20progression%20of%20heart%20failure.%20We%20evaluated%20the%20therapeutic%20efficacy%20of%20the%20polyether%20ionophore%20salinomycin%20in%20patient%20derived%20cardiac%20fibroblasts%20and%20pre-clinical%20mouse%20models%20of%20ischemic%20and%20non-ischemic%20heart%20failure.%20Methods%20and%20Results%3A%20Here%2C%20we%20demonstrate%20that%20salinomycin%20displays%20potent%20anti-fibrotic%20activity%20in%20cardiac%20fibroblasts%20obtained%20from%20heart%20failure%20patients.%20In%20pre-clinical%20studies%2C%20salinomycin%20prevents%20cardiac%20fibrosis%20and%20functional%20decline%20in%20mouse%20models%20of%20ischemic%20and%20non-ischemic%20heart%20disease.%20Remarkably%2C%20interventional%20treatment%20with%20salinomycin%20attenuates%20pre-established%20pathological%20cardiac%20remodeling%20secondary%20to%20hypertension%2C%20and%20limits%20scar%20expansion%20when%20administered%20after%20a%20severe%20myocardial%20infarction.%20Mechanistically%2C%20salinomycin%20inhibits%20cardiac%20fibroblast%20activation%20by%20preventing%20p38%5C%2FMAPK%20and%20Rho%20signaling.%20Salinomycin%20also%20promotes%20cardiomyocyte%20survival%20and%20improves%20coronary%20vessel%20density%2C%20suggesting%20that%20cardioprotection%20conferred%20by%20salinomycin%20occurs%20via%20the%20integration%20of%20multiple%20mechanisms%20in%20multiple%20relevant%20cardiac%20cell%20types.%20Conclusions%3A%20These%20data%20establish%20salinomycin%20as%20an%20anti-fibrotic%20agent%20that%20targets%20multiple%20cardioprotection%20pathways%2C%20thereby%20holding%20promise%20for%20the%20treatment%20of%20heart%20failure%20patients.%22%2C%22date%22%3A%22%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1161%5C%2FCIRCRESAHA.120.317791%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ahajournals.org%5C%2Fdoi%5C%2F10.1161%5C%2FCIRCRESAHA.120.317791%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-09T16%3A05%3A35Z%22%7D%7D%5D%7D
Burke Ryan M, Dirkx, Jr. R. A., Quijada Pearl, Lighthouse Janet K, Mohan Amy, O’Brien Meghann, Wojciechowski Wojciech, Woeller Collynn, Phipps Richard P, Alexis Jeffrey D, Ashton John, & Small Eric M. (n.d.). Prevention of Fibrosis and Pathological Cardiac Remodeling by Salinomycin. Circulation Research, 0(0). https://doi.org/10.1161/CIRCRESAHA.120.317791 Cite
